Heart Attack Diagnostics Market

Heart Attack Diagnostics Market by Test Types (Electrocardiogram, Blood Tests [Troponin and Creatine Kinase MB Isoenzyme] and Echocardiogram) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-672
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 184
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global heart attack diagnostics market size is estimated to expand at a considerable CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to rising prevalence of heart disease cases, increasing research & government initiatives, and increasing health expenditure.

Heart Attack Diagnostics Market Key Takeaways

Heart attack, also known as Myocardial Infarction (MI), is a type of heart disease that generally occurred when heart stops its normal function. Without proper medications or medical guidelines, patients with heart diseases have a high risk of heart attack or cardiac arrest that can cause death. The pathophysiology of heart attack includes tissue necrosis of myocardium layer of heart. Atherosclerosis, as a deposition of thrombotic plaques in the arteries, can cause ischaemia (reduced blood supply to tissues), which resulting in low oxygen supply known as hypoxia. Due to hypoxia, thrombotic plaques get deposited and cause tissue death in the layer of heart that ultimately cause myocardial infarction. Apart from this, some diseases and conditions are responsible for heart attack such as coronary artery disease (CAD), atrial fibrillation, cardiomyopathy, cardiomegaly, congestive heart failure, and angina pectoris. Among these, CAD is a major cause of heart attack. Symptoms related to heart condition include chest pain, pain in neck, and shortness of breath. According to World Health Organisation (WHO), heart attack caused around 17.9 million deaths globally.

Heart attack diagnosis includes different types of methods such as electrocardiogram (ECG), blood test, chest X-ray, echocardiogram, coronary catheterization or angiogram, and cardiac magnetic resonance imaging (cMRI). These methods can detect the conditions or chances of heart attack. Some of the common drug treatment for heart attack include aspirin, streptokinase, clopidogrel, rivaroxaban, nitro-glycerine, propranolol, captopril, and atorvastatin.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising incidence of CAD and heart stroke, growing number of aging populaces, and inactive lifestyle can fuel the market expansion in the upcoming years.
  • Increasing tobacco consumption & alcoholism, rising prevalence of obesity and high blood pressure & diabetes, and improper diet are expected to boost the market expansion during the forecast period.
  • The outbreak of COVID-19 pandemic has raised the demand for the heart attack diagnostic and rising awareness of heart disease patients who require regular diagnosis are projected to propel the market growth.
  • High cost of heart attack therapy is acting a major challenge expected to hamper the market growth in the coming years.
  • Rising research collaborations to develop advanced technology and increasing government initiatives for the development of healthcare infrastructure can create lucrative opportunities for the market expansion during the forecast period.

Scope of the Report

The report on the global heart attack diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Heart Attack Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Test Types (Electrocardiogram, Blood Tests [Troponin and Creatine Kinase MB Isoenzyme], and Echocardiogram)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Siemens Healthcare AG; Midmark Corporation; Schiller AG; Koninklijke Phillips N.V.; Hitachi healthcare; Toshiba International Corporation; F. Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Bio-Rad Laboratories Inc.; Beckman Coulter, Inc.; AstraZeneca; Pfizer Inc., and Danaher Corporation


Global Heart Attack Diagnostics Market Segment Insights

Blood test segment is expected to grow at a rapid pace
Based on test types, the global heart attack diagnostics market is divided into electrocardiogram, blood tests, and echocardiogram. The blood tests segment is further subdivided into troponin and creatine kinase MB isoenzyme (CK-MB). The blood tests segment held a major market share in terms of revenue generation in 2020 and is expected to grow at rapid pace during the forecast period from 2021-2028. Wide uses of troponin blood test for detection of heart disease across the globe is projected to boost the blood test segment.

Heart Attack Diagnostics Market By Test Types

Asia Pacific is projected to accounts for a key share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in terms of revenue generation in 2020 and is projected to represent a key market share in the coming years. The regional market growth can be attributed to rising awareness and health expenditure on heart disease, desk-bound lifestyle, and adoption of advanced technology. However, Asia Pacific is projected to register a robust CAGR during the forecast period due to high incidence rate of heart disease, rising healthcare expenditure for cardiovascular diseases, and high aging populace in the region.

 Heart Attack Diagnostics Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Heart Attack Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Heart Attack Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Heart Attack Diagnostics Market - Supply Chain
  4.5. Global Heart Attack Diagnostics Market Forecast
     4.5.1. Heart Attack Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Heart Attack Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Heart Attack Diagnostics Market Absolute $ Opportunity
5. Global Heart Attack Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Heart Attack Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Heart Attack Diagnostics Demand Share Forecast, 2019-2026
6. North America Heart Attack Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Heart Attack Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Heart Attack Diagnostics Demand Share Forecast, 2019-2026
7. Latin America Heart Attack Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Heart Attack Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Heart Attack Diagnostics Demand Share Forecast, 2019-2026
8. Europe Heart Attack Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Heart Attack Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Heart Attack Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific Heart Attack Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Heart Attack Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Heart Attack Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa Heart Attack Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Heart Attack Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Heart Attack Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Heart Attack Diagnostics Market: Market Share Analysis
  11.2. Heart Attack Diagnostics Distributors and Customers
  11.3. Heart Attack Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Siemens Healthcare AG
     11.4.2. Midmark Corporation
     11.4.3. Schiller AG
     11.4.4. Koninklijke Phillips N.V.
     11.4.5. Hitachi healthcare
     11.4.6. Toshiba International Corporation
     11.4.7. F. Hoffmann-La Roche Ltd.
     11.4.8. Abbott Laboratories Inc.
     11.4.9. Bio-Rad Laboratories Inc.
     11.4.10. Beckman Coulter, Inc.
Segments Covered in the Report
The global heart attack diagnostics market has been segmented on the basis of

Test Types
  • Electrocardiogram
  • Blood Tests
    • Troponin
    • Creatine Kinase MB Isoenzyme (CK-MB)
  • Echocardiogram
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Siemens Healthcare AG
  • Midmark Corporation
  • Schiller AG
  • Koninklijke Phillips N.V.
  • Hitachi healthcare
  • Toshiba International Corporation
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories Inc.
  • Beckman Coulter, Inc.
  • AstraZeneca
  • Pfizer Inc.
  • Danaher Corporation

Some of the key players in the market are Siemens Healthcare AG; Midmark Corporation; Schiller AG; Koninklijke Phillips N.V.; Hitachi healthcare; Toshiba International Corporation; F. Hoffmann-La Roche Ltd; Abbott Laboratories Inc.; Bio-Rad Laboratories Inc; Beckman Coulter, Inc.; AstraZeneca; Pfizer Inc., and Danaher Corporation. Many of these key players are actively investing in research & development to develop new technologies and also actively engaged in various market strategies. Some of the key strategies adopted by players are product launches, mergers, partnerships, acquisitions, and expansion of production units to enhance their market position and expand their consumer base across the globe.

In May 2019, Abbott introduced a new technology for implantable cardiac monitor (ICM), which offered to observe cardiac pulse. In August 2015, Schiller AG developed CARDIOVIT FT-1 that proved to be useful for continuous monitoring of heart beat.

 Heart Attack Diagnostics Market By Key Players

Buy Report